Back to results
US 11,077,119 B2Granted
Enhanced brain bioavailability of galantamine by selected formulations and transmucosal administration of lipophilic prodrugs
AssigneeNeurodyn Life Sciences Inc.
InventorAlfred Maelicke
Life of this patent
Estimating the term…
Abstract
A method of treating a subject for a brain disease associated with cognitive impairment, including administering to a subject a chemical substance according to GLN-1062 or salt thereof: wherein the treatment includes transmucosal administration of a therapeutically effective amount of GLN 1062 or salt thereof in the oral cavity of the subject.
Claims13
A method of treating a subject for a brain disease associated with cognitive impairment, comprising administering to a subject a chemical substance according to GLN 1062 or salt thereof:
- wherein said treatment comprises sublingual administration of a therapeutically effective amount of GLN 1062 or salt thereof in the oral cavity of the subject.
Dependencies are inferred from the claim text.